Harvard Bioscience, Inc. (HBIO) Reports Q1 EPS of $0.09; Guides Q2
Tweet Send to a FriendGet Alerts HBIO Hot Sheet
Price: $5.06 +1.61%
EPS Growth %: -11.1%
Financial Fact:
Diluted earnings per common share: 0
Today's EPS Names:
CO, JW-A, FDS, More
EPS Growth %: -11.1%
Financial Fact:
Diluted earnings per common share: 0
Today's EPS Names:
CO, JW-A, FDS, More
Trade HBIO Now!
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q1 EPS of $0.09, versus $0.08 reported last year. Revenue for the quarter came in at $28.3 million, versus $26.3 million reported last year.
Harvard Bioscience, Inc. sees Q2 2012 EPS of $0.06-$0.06. Harvard Bioscience, Inc. sees Q2 2012 revenue of $28-$29 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Harvard Bioscience, Inc. sees Q2 2012 EPS of $0.06-$0.06. Harvard Bioscience, Inc. sees Q2 2012 revenue of $28-$29 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- La-Z-boy, Inc. (LZB) Tops Q4 EPS by 5c
- Korn/Ferry Int'l (KFY) Tops Q4 EPS by 1c, Offers Q1 Guidance
- Lentuo International (LAS) Swings to Q1 Loss; Updates on Expansion
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
